Singapore: The China Food and Drug Administration made an announcement that China's top drug authority has licensed a do...
Singapore: Scientists at A*Star's Singapore Immunology Network (SIgN) have discovered a clue that has the potential to c...
Singapore: QPS Holdings, a leading full-service clinical research organization, announced the launch of its QPS Qualiti...
Singapore: Janssen Pharmaceutical has terminated the research and development alliance with China based Hutchison Mediph...
Singapore: Adults should consume less than 2,000 mg of sodium, or 5 grams of salt, and at least 3,510 mg of potassium pe...
Asia attracted a lot of interest from foreign multinational giants in the year 2013. This not only led to the increase i...
Singapore: ShangPharma entered into a definitive agreement and plan of merger with ShangPharma Holdings, ShangPharma Pa...
Singapore: WuXi PharmaTech, research and technology platform company serving the pharmaceutical, biotechnology, and medi...
Singapore: IMPACT Therapeutics, a company dedicated to the discovery, development and commercialization of novel and "be...
Singapore: According to a report issued by Chinese drug authority, online sales of medicines are skyrocketing in China w...
Singapore: Regeneron Pharmaceuticals and Bayer HealthCare have initiated a new phase III trial (named Vivid East-DME) t...
Singapore: PerkinElmer, has announced that it has received market authorization from the China Food and Drug Administrat...
Singapore: The Chinese Food and Drug Administration has approved the use of 3D printed hip implants in China, a breakthr...
Singapore: Gilead Sciences and WuXi PharmaTech have entered into a strategic partnership to conduct analytical and stabi...
Singapore: OxOnc Development, an oncology development company founded by pharmaceutical development executives and oncol...
The investments pouring in China are aligned with the government's plan to boost the pharmaceutical industry of the coun...
Singapore: Literally all the roads led to the swanky National Exhibition and Convention Center (NECC), Shanghai as over...
Singapore: Boehringer Ingelheim and Eli Lilly and Company have presented their results from two randomized phase III cli...
